| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | 0.06 | 0.09 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.059 | 0.09 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | 0.087 | 0.09 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.09 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | -0.051 | 0.09 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.055 | 0.09 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.054 | 0.09 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.09 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | 0.062 | 0.09 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.055 | 0.09 |